Influence of CYP2D6 activity on the pharmacokinetics and pharmacodynamics of a single 20 mg dose of ibogaine in healthy volunteers Read More > February 4, 2015
Forbidden therapies: Santo Daime, ayahuasca, and the prohibition of entheogens in Western society Read More > February 1, 2015
Preliminary analysis of positive and negative syndrome scale in ketamine-associated psychosis in comparison with schizophrenia Read More > February 1, 2015
Antidepressant actions of ketamine: from molecular mechanisms to clinical practice Read More > February 1, 2015
Editorial (Thematic Issue: Introduction to 'Beneficial Effects of Psychedelics with a Special Focus on Addictions') Read More > January 28, 2015
Editorial (Thematic Issue: Introduction to ‘Beneficial Effects of Psychedelics with a Special Focus on Addictions’) Read More > January 28, 2015
Ayahuasca, Psychedelic Studies and Health Sciences: The Politics of Knowledge and Inquiry into an Amazonian Plant Brew Read More > January 28, 2015
Crisis Intervention Related to the Use of Psychoactive Substances in Recreational Settings – Evaluating the Kosmicare Project at Boom Festival Read More > January 28, 2015
Psychedelics as Medicines for Substance Abuse Rehabilitation: Evaluating Treatments with LSD, Peyote, Ibogaine and Ayahuasca Read More > January 28, 2015
